Signal · Product Feed

ENMD-2076 60090 pharmacokinetics and clinical activity of

ENMD-2076 60090 pharmacokinetics and clinical activity of

Name: ENMD-2076 60090 pharmacokinetics and clinical activity of
Brand: matisco.be
SKU: 72740784094
Price: 95.00 USD
Availability: InStock
Rating: 4.2142 (23 reviews)

SKU: 72740784094

4.2

USD95.00 USD125.00

Pay in 4 interest-free payments of $23.75 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

Live Spec

ENMD-2076 60090 pharmacokinetics and clinical activity ofENMD 2076 is an orally active, Aurora A angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD 2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over expressed in human cancers. ENMD 2076 also targets the VEGFR, Flt 3 and FGFR3 kinases which have been

Store: matisco.be · Domain: matisco.be

Description

pharmacokinetics and clinical activity of VS-6063

InChi: InChI=1S/C26H31N3O3/c1-25(2

OC 144-093

and improves lipid profile

Exchange/Return Notes